TY  - JOUR 
AU  - García Campelo, María del Rosario
PY  - 2012
SN  - 1470-2045
UR  - http://hdl.handle.net/20.500.11940/7760
LA  - eng
TI  - Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial
DO  - 10.1016/S1470-2045(11)70393-X
T2  - LANCET ONCOLOGY
VL  - 13
ER  -